Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes

NCT01707134 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
753
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novo Nordisk A/S